Alleviare Life Sciences Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Alleviare Life Sciences Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $76.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Alleviare Life Sciences Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $76.8K Trade | TransData Nexus

Alleviare Life Sciences Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $76.8K Total Trade · DGFT Verified

Alleviare Life Sciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $76.8K across 3 products in 1 therapeutic categories. Based on 18 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Daratumumab ($31.0K), Pembrolizumab ($23.9K), Lenvatinib ($21.9K).

Alleviare Life Sciences Private Limited — Export Portfolio & Destination Treemap

Alleviare Life Sciences Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Alleviare Life Sciences Private Limited? — Company Overview & Market Position

Alleviare Life Sciences Private Limited is a privately held pharmaceutical company established on December 10, 2013, in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U74999DL2013PTC261897 and is classified as a non-government company limited by shares. Its authorized capital is ₹1.0 million, with a paid-up capital of ₹0.43 million.

The company's registered office is located at S-9, Mezzanine Floor, Uphaar Cinema Complex, Green Park Extension, New Delhi, Delhi, 110016, India. Alleviare Life Sciences specializes in the global export of specialty drugs, including vaccines and cold chain pharmaceutical products, as well as general pharmaceutical products. Additionally, the company provides consulting services to Indian patients for medicines that are not available or registered in India, assisting with documentation, logistics, and procurement from international authorized suppliers.

What Does Alleviare Life Sciences Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Daratumumab$31.0K 2

Product Portfolio — Top 3 by Export Value

Alleviare Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Daratumumab	Advanced Oncology	$31.0K	6	2.3%	12
2	Pembrolizumab	Advanced Oncology	$23.9K	3	1.2%	13
3	Lenvatinib	Advanced Oncology	$21.9K	9	1.0%	13

Alleviare Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $76.8K. The top category is Advanced Oncology (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Alleviare Life Sciences Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Alleviare Life Sciences Private Limited's manufacturing facilities are not publicly disclosed. The company primarily focuses on the export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, rather than manufacturing raw active pharmaceutical ingredients (APIs) or bulk drugs. This strategic approach suggests that Alleviare Life Sciences may partner with established manufacturers to produce its product offerings.

3Key Leadership

As of November 15, 2023, the directors of Alleviare Life Sciences Private Limited are Vaibhav Bansal and Puneet Poddar. The company's leadership team comprises professionals with extensive experience in the pharmaceutical industry, enabling Alleviare Life Sciences to supply and deliver a wide range of products within short notice.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Alleviare Life Sciences Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Alleviare Life Sciences Private Limited's export activities are primarily focused on the Indian market, with limited publicly available information regarding its presence in other regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan. The company's export value of $77,000 USD across 18 shipments, with a portfolio concentration of 100% in the Advanced Oncology therapeutic category, indicates a niche market focus. The top three exported products—Daratumumab, Pembrolizumab, and Lenvatinib—are all oncology treatments, suggesting that the company may be targeting markets with a high demand for cancer therapies.

2Emerging Markets

Alleviare Life Sciences Private Limited's export data does not provide specific insights into its penetration in emerging markets such as Africa, Latin America, and Southeast Asia. The company's focus on specialty drugs, including oncology treatments, may position it to explore opportunities in regions with growing healthcare needs and increasing demand for advanced medical therapies. However, without explicit information on regulatory approvals or market access in these regions, a comprehensive assessment is challenging.

3Geographic Strategy

Alleviare Life Sciences Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Publicly available information does not disclose Alleviare Life Sciences Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. The company's export data indicates a focus on finished pharmaceutical formulations, including oncology treatments, but without explicit details on FDA approvals or compliance, a thorough assessment of its standing with the U.S. Food and Drug Administration is not feasible.

2WHO & EU GMP

There is no publicly available information confirming whether Alleviare Life Sciences Private Limited holds World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certificates. The company's export data suggests a focus on finished pharmaceutical formulations, but without explicit details on WHO or EU GMP certifications, an assessment of its compliance with these international standards cannot be made.

3CDSCO & Indian Regulatory

Alleviare Life Sciences Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Alleviare Life Sciences Private Limited operates in the competitive pharmaceutical export market, focusing on specialty drugs, particularly in the oncology therapeutic area. While specific competitors are not identified in the available data, the company's niche focus on oncology treatments positions it within a specialized segment of the market. The export value of $77,000 USD across 18 shipments suggests a selective approach to market entry, potentially targeting regions with high demand for oncology therapies. However, without explicit information on market share or direct competitors, a detailed competitive analysis is not feasible.

2Key Differentiators

Alleviare Life Sciences Private Limited's key differentiators include its specialization in the export of specialty drugs, particularly oncology treatments, and its consulting services for Indian patients seeking access to medicines not available or registered in India. The company's focus on finished pharmaceutical formulations, including vaccines and cold chain products, indicates a commitment to providing comprehensive solutions in the pharmaceutical export sector. Additionally, the leadership team's extensive experience in the pharmaceutical industry enables the company to supply and deliver a wide range of products within short notice.

Strategic Position

Buyer Due Diligence Brief — Evaluating Alleviare Life Sciences Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Alleviare Life Sciences Private Limited's export data indicates a focus on finished pharmaceutical formulations, including oncology treatments. The company's export value of $77,000 USD across 18 shipments suggests a selective approach to market entry, potentially mitigating risks associated with overextension. However, without explicit information on supplier relationships, manufacturing capabilities, or compliance with international standards, a thorough assessment of the company's reliability as a supplier is not feasible.

2Certifications to Verify

Importers considering Alleviare Life Sciences Private Limited as a supplier should verify the following certifications:

FDA Facility Registration: Confirm that the company's manufacturing facilities are registered with the U.S. Food and Drug Administration (FDA). This can be verified through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: Ensure that the company holds World Health Organization (WHO) Good Manufacturing Practice (GMP) certification. This can be verified by checking the WHO's official website or by requesting certification details from the company.

Frequently Asked Questions — Alleviare Life Sciences Private Limited

How many pharmaceutical products does Alleviare Life Sciences Private Limited export from India?

Alleviare Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Daratumumab ($31.0K), Pembrolizumab ($23.9K), Lenvatinib ($21.9K). Total export value is $76.8K.

What is Alleviare Life Sciences Private Limited's total pharmaceutical export value?

Alleviare Life Sciences Private Limited's total pharmaceutical export value is $76.8K, based on 18 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Alleviare Life Sciences Private Limited cover?

Alleviare Life Sciences Private Limited exports across 1 therapeutic categories. The largest are Advanced Oncology (100.0%, 3 products).

Get Full Alleviare Life Sciences Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.